Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2269-2273

  Van Der Hoek, Ytje Y ^a,b   Lingenhel, Arno ^c   Kraft, Hans G ^c,d   Defesche, Joep C ^a   Kastelein, John J P ^a   Utermann, Gerd ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d Inst of Med Biol and Hum Genet   (Austria)

Author keywords

apolipoprotein(a); Familial Defective apoB; lipoprotein(a); sib pair analysis; variability gene

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIBLING; THROMBOGENICITY;

EID: 0030911569     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119402     Document Type: Article

References (46)

1. Utermann, G. 1994. Lipoprotein(a). In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, J.B. Stanbury, J.B. Wyngaarden, and D.S. Fredrickson, editors. McGraw-Hill Inc., New York. 1887-1912.
2. Boerwinkle, E., C.C. Leffert, J. Lin, C. Lackner, G. Chiesa, and H.H. Hobbs. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90:52-60.
3. Demeester, C.A., X. Bu, R.J. Gray, A.J. Lusis, and J.I. Rotter. 1995. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am. J. Hum. Genet. 56:287-293.
4. Kraft, H.G., S. Köchl, H.J. Menzel, C. Sandholzer, and G. Utermann. 1992. The apolipoprotein(a) gene-a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum. Genet. 90:220-230.
5. Brewer, H.B., Jr. 1992. Effectiveness of diets and drugs in the treatment of patients with elevated Lp(a) levels. In Lipoprotein(a). A.M. Scanu, editor. Academic Press Inc., Orlando, FL. 211-220.
6. Kostner, G.M., G. Klein, and F. Krempler. 1984. Can serum lipoprotein(a) concentration be lowered by drugs and/or diet? In Treatment of Hyperlipoproteinemia. C.A. Carlson and A.G. Olsen, editors. Raven Press, New York. 151 pp.
7. Utermann, G. 1989. The mysteries of lipoprotein(a). Science (Wash. DC). 246:904-910.
8. Brunner, C., H.G. Kraft, G. Utermann, and H.J. Müller. 1993. Cysteine 4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc. Natl. Acad. Sci. USA. 90:11643-11647.
9. Gaubatz, J.W., C. Heideman, A.M.J. Gotto, J.D. Morrisett, and G.H. Dahlen. 1983. Human plasma lipoprotein (a): structural properties. J. Biol. Chem. 258:4582-4589.
10. Koschinsky, M.L., G.P. Cote, B. Gabel, and Y.Y. Van der Hoek. 1993. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J. Biol. Chem. 268:19819-19825.
11. McLean, J.W., J.E. Tomlinson, W. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu, and R.M. Lawn. 1987. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature (Lond.). 300:132-137.
12. Floren, S., J.J. Albers, and E.L. Bierman. 1981. Uptake of Lp(a) lipoprotein by cultured fibroblasts. Biochem. Biophys. Res. Commun. 10:636-639.
13. Havekes, L., B.J. Vermeer, T. Brugman, and J. Emeis. 1981. Binding of Lp (a) to the low density lipoprotein receptor of human fibroblast. FEBS (Fed. Eur. Biochem. Soc.) Lett. 132:169-173.
14. Hofmann, S.L., D.L. Eaton, M.S. Brown, J.W. McConathy, J.L. Goldstein, and R.E. Hammer. 1990. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J. Clin. Invest. 85:1542-1547.
15. Krempler, F., G.M. Kostner, A. Roscher, F. Haslauer, K. Bolzano, and F. Sandhofer. 1982. Studies on the role of specific cell surface receptors in the removal of lipoprotein(a) in man. J. Clin. Invest. 71:1431-1441.
16. Maartman-Moe, K., and K. Berg. 1981. Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor. Clin. Genet. 20:352-362.
17. Rader, D.J., W.A. Mann, W. Cain, H.G. Kraft, D. Usher, L.A. Zech, J.M. Hoeg, J. Davignon, M. Grossman, J.M. Wilson, and H.B. Brewer, Jr. 1995. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J. Clin. Invest. 95:1403-1408.
18. Hansen, A.T., and S.E. Humphries. 1992. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis. 96:91-107.
19. Innerarity, T.L., K.H. Weisgraber, K.S. Arnold, R.W. Mahley, R.M. Krauss, G.L. Vega, and S.M. Grundy. 1987. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc. Natl. Acad Sci USA. 84:6919-6923.
20. Defesche, J.C., K.L. Pricker, M.R. Hayden, B.E. Vanderende, and J.J.P. Kastelein. 1993. Familial defective apolipoprotein B-100 is clinically indistin-guishable from familial hypercholesterolemia. Arch. Intern. Med. 153:2349-2356.
21. Defesche, J.C., J.E. Hoogendijk, M. de Visser, O. de Visser, and P.A. Bolhuis. 1990. Genetic linkage of hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease) to markers of chromosomes 1 and 17. Neurology. 40:1450-1453.
22. Demacker, P.N.M., J.B.H.A. Van Oppenraay, H. Baadenhuijsen, and A.P. Jansen. 1975. An improved semi automatic method for the colorimetric determination of triglycerides in serum. Clin. Chim. Acta. 64:45-50.
23. Rochlau, P., E. Bernt, and W. Gruber. 1974. Enzymalische Bestimmung des Gesamtcholesterins im Serum. J. Clin. Biochem. 12:403-407.
24. Demacker, P.N.M., A.G.M. Hijmans, H.E. Vos-Jansen, A. Van't Laarsen, and A.P. Jansen. 1980. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein. Clin. Chem. 26:1775-1779.
25. Friedewald, W.T., R.I. Levy, and D.S. Fredrickson, 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifugation. Clin. Chem. 18:499-502.
26. Gaubatz, J.W., G.L. Cushing, and J.D. Morrisett. 1986. Quantitation, isolation and characterization of human lipoprotein(a). Methods Enzymnl. 129:167-186.
27. Kronenberg, F., E. Lobentanz, P. König, G. Utermann, and H. Dieplinger. 1994. Effect of sample storage on the measurement of lipoprotein(a), apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J. Lipid Res. 35:1318-1328.
28. Snyder, M.L., D. Polacek, A.M. Scanu, and G.M. Fless. 1992. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. J. Biol. Chem. 267:339-346.
29. März, W., A. Beckmann, H. Scharnagl, R. Siekmeier, U. Mondorf. I. Held, W. Schneider, K.T. Preissner, L.K. Curtiss, W. Gross, and M. Hüttinger. 1993. Heterogeneous lipoprotein(a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor. FEBS (Fed. Eur. Biochem. Soc.) Lett. 325:271-275.
30. Utermann, G., F. Hoppichler, H. Dieplinger, M. Seed, G. Thompson, and E. Boerwinkle. 1989. Defects in the LDL receptor gene affect Lp (a) lipoprotein levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc. Natl. Acad. Sci. USA. 86:4171-4174.
31. Bowden, J.F., P.H. Pritchard, J.S. Hill, and J.J. Frohlich. 1994. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia. Arterioscler. Thromb. 14:1561-1568.
32. Mbewu, A.D., D. Bhatnagar, P.N. Durrington, L. Hunt, M. Ishola, S. Arrol, M. Mackness, P. Lockley, and J.P. Miller. 1991. Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations. Arterioscler. Thromb. 11:940-946.
33. Seed, M., F. Hoppichler, D. Reaveley, S. McCarthy, G.R. Thompson, E. Boerwinkle, and G. Utermann. 1990. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N. Engl. J. Med. 322:1494-1499.
34. Wiklund, O., B. Angelin, S.-O. Olofsson, M. Eriksson, G. Fager, L. Berglund, and G. Bondjers. 1990. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet (N. Am. Ed.). 335:1360-1363.
35. Carmena, R., S. Lussier Cacan, M. Roy, A. Minnich, A. Lingenhel, F. Kronenberg, and J. Davignon. 1996. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterioscler. Thromb. Vasc. Biol. 16:129-136.
36. Defesche, J.C., M.A. van de Ree, J.J. Kastelein, D.E. van Diermen, N.W. Janssens, J.J. van Doormaal, and M.R. Hayden. 1992. Detection of the Pro664-Leu mutation in the low-density lipoprotein receptor and its relation to lipoprotein(a) levels in patients with familial hypercholesterolemia of Dutch ancestry from The Netherlands and Canada. Clin. Genet. 42:273-280.
37. Friedlander, Y., and E. Leitersdorf. 1995. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia. Genet. Epidemiol. 12:129-143.
38. Ghiselli, G., A. Gaddi, G. Barozzi, A. Ciarrocchi, and G. Descovich. 1992. Plasma lipoprotein(a) concentration in familial hypercholesterolemic patients without coronary artery disease. Metab. Clin. Exp. 41:833-838.
39. Leitersdorf, E., Y. Friedlander, J.M. Bard, J.C. Fruchart, S. Eisenberg, and Y. Stein. 1991. Diverse effect of ethnicity on plasma lipoprotein(a) levels in heterozygote patients with familial hypercholesterolemia. J. Lipid. Res. 32:1513-1519.
40. Perombelon, Y.N.F., A.K. Soutar, and B.L. Knight. 1994. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J. Clin. Invest. 93:1481-1492.
41. Perombelon, Y.N.F., J.J. Gallagher, N.B. Myant, A.K. Soutar, and B.L. Knight. 1992. Lipoprotein(a) in subjects with familial defective apolipoprotein B100. Atherosclerosis. 92:203-212.
42. Hansen, P.S., H. Meinertz, H.K. Jensen, P. Fruergaard, J. Launbjerg, I.C. Klausen, L. Lemming, U. Gerdes, N. Gregersen, and O. Faergeman. 1994. Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100. Arterioscler. Thromb. 14:207-213.
43. Lackner, C., E. Boerwinkle, C.C. Leffert, T. Rahming, and H.H. Hobbs. 1991. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J. Clin. Invest. 87:2153-2161.
44. Utermann, G., H.J. Menzel, H.G. Kraft, C.H. Duba, H.G. Kemmler, and C. Seitz. 1987. Lp(a) glycoprotein phenotype. Inheritance and relation to Lp(a)-lipoprotein concentration in plasma. J. Clin. Invest. 80:458-465.
45. Magnus, P., K. Berg, A.L. Borresen, and W.E. Nance. 1981. Apparent influence of marker genotypes on variation in serum cholesterol in monozygotic twins. Clin. Genet. 19:67-70.
46. Berg, K. 1990. Level genes and variability genes in the etiology of hyperlipidemia and atherosclerosis. In From Phenotype to Gene in Common Disorders. K. Berg, N. Retterstol, and S. Refsum, editors. Munksgaard International Publishers Ltd., Copenhagen. 77-91.